Isotretinoin dosing: past, present, and future trends. Seminars in cutaneous medicine and surgery. [Semin Cutan Med Surg] Journal article | | Title | Isotretinoin dosing: past, present, and future trends. | | Author(s) | Hirsch RJ, Shalita AR | | Institution | SUNY Downstate Medical Center, Brooklyn, NY 11203, USA. | | Source | Semin Cutan Med Surg 2001 Sep; 20(3):162-5. | | MeSH | Acne Vulgaris
Dermatologic Agents
Humans
Isotretinoin
| | Abstract | Isotretinoin is the treatment of choice for severe nodulocystic acne. It represents the sole agent that effectively addresses all of the pathophysiological factors in the production of acne. Dosing recommendations are based on European trials that included patients with nonacne skin disease, which requires higher doses of isotretinoin for clearance. In this article, the authors relate their extensive experience with dosing regimens for acne as well as discuss recommendations for length of therapy. | | Language | eng | | Pub Type(s) | Journal Article
Review
| | PubMed ID | 11594671 |
|
|
| |
Advertise on this site.
| | |
|
